EZH2 and pulmonary arterial hypertension: Experimental studies have shown that EZH2 overexpression enhances proliferation, migration and apoptosis resistance of pulmonary artery VSMCs in the mice with hypoxia-mediated PAH (Aljubran et al., 2012; Saco et al., 2014).